| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 1045 | 2021 |
| Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study TM Walker, CLC Ip, RH Harrell, JT Evans, G Kapatai, MJ Dedicoat, ... The Lancet infectious diseases 13 (2), 137-146, 2013 | 988 | 2013 |
| Oral versus intravenous antibiotics for bone and joint infection HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ... New England Journal of Medicine 380 (5), 425-436, 2019 | 748 | 2019 |
| Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing DW Eyre, ML Cule, DJ Wilson, D Griffiths, A Vaughan, L O'Connor, CLC Ip, ... New England Journal of Medicine 369 (13), 1195-1205, 2013 | 736 | 2013 |
| Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study TM Walker, TA Kohl, SV Omar, J Hedge, CDO Elias, P Bradley, Z Iqbal, ... The Lancet infectious diseases 15 (10), 1193-1202, 2015 | 641 | 2015 |
| Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK KB Pouwels, E Pritchard, PC Matthews, N Stoesser, DW Eyre, KD Vihta, ... Nature medicine 27 (12), 2127-2135, 2021 | 624 | 2021 |
| Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis P Bradley, NC Gordon, TM Walker, L Dunn, S Heys, B Huang, S Earle, ... Nature communications 6 (1), 10063, 2015 | 619 | 2015 |
| Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy Z Jaunmuktane, S Mead, M Ellis, JDF Wadsworth, AJ Nicoll, J Kenny, ... Nature 525 (7568), 247-250, 2015 | 579 | 2015 |
| Determinants of survival following HIV-1 seroconversion after the introduction of HAART Cascade Collaboration The Lancet 362 (9392), 1267-1274, 2003 | 533 | 2003 |
| Multilocus sequence typing of Clostridium difficile D Griffiths, W Fawley, M Kachrimanidou, R Bowden, DW Crook, R Fung, ... Journal of clinical microbiology 48 (3), 770-778, 2010 | 490 | 2010 |
| Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial C Chintu, GJ Bhat, AS Walker, V Mulenga, F Sinyinza, K Lishimpi, ... The Lancet 364 (9448), 1865-1871, 2004 | 480 | 2004 |
| Within-host evolution of bacterial pathogens X Didelot, AS Walker, TE Peto, DW Crook, DJ Wilson Nature Reviews Microbiology 14 (3), 150-162, 2016 | 470 | 2016 |
| Effect of Covid-19 vaccination on transmission of alpha and delta variants DW Eyre, D Taylor, M Purver, D Chapman, T Fowler, KB Pouwels, ... New England Journal of Medicine 386 (8), 744-756, 2022 | 446 | 2022 |
| The challenge of antimicrobial resistance: What economics can contribute LSJ Roope, RD Smith, KB Pouwels, J Buchanan, L Abel, P Eibich, ... Science 364 (6435), eaau4679, 2019 | 445 | 2019 |
| A Candida auris Outbreak and Its Control in an Intensive Care Setting DW Eyre, AE Sheppard, H Madder, I Moir, R Moroney, TP Quan, ... New England Journal of Medicine 379 (14), 1322-1331, 2018 | 439 | 2018 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber, PLATO collaboration The Lancet 364 (9428), 51-62, 2004 | 391 | 2004 |
| Prediction of Staphylococcus aureus antimicrobial resistance by whole-genome sequencing NC Gordon, JR Price, K Cole, R Everitt, M Morgan, J Finney, AM Kearns, ... Journal of clinical microbiology 52 (4), 1182-1191, 2014 | 388 | 2014 |
| Same-day diagnostic and surveillance data for tuberculosis via whole-genome sequencing of direct respiratory samples AA Votintseva, P Bradley, L Pankhurst, C del Ojo Elias, M Loose, ... Journal of clinical microbiology 55 (5), 1285-1298, 2017 | 385 | 2017 |
| Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial DART Trial Team The Lancet 375 (9709), 123-131, 2010 | 368 | 2010 |
| Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion Cascade Collaboration Aids 20 (5), 741-749, 2006 | 347 | 2006 |
Nicole StoesserVerified email at ndm.ox.ac.uk
